| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TFAP2C mRNA" | 25510870 |
| C029497 | 2,3-bis(3'-hydroxybenzyl)butyrolactone | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFAP2C mRNA" | 19167446 |
| C081766 | 2,4,4'-trichlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TFAP2C mRNA" | 25510870 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TFAP2C mRNA" | 25510870 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TFAP2C mRNA" | 25510870 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TFAP2C mRNA" | 25510870 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| D000638 | Amiodarone | Amiodarone results in increased expression of TFAP2C mRNA | 19774075 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of TFAP2C mRNA | 15761015 |
| C015001 | arsenite | arsenite results in increased methylation of TFAP2C promoter | 23974009 |
| D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of TFAP2C mRNA" | 18687144 |
| D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in decreased expression of TFAP2C mRNA" | 19446018 |
| C487081 | belinostat | belinostat results in increased expression of TFAP2C mRNA | 26272509 |
| C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of TFAP2C mRNA | 23735875 |
| D004958 | Estradiol | Estradiol affects the expression of TFAP2C mRNA | 23557687 |
| D004958 | Estradiol | Estradiol affects the expression of TFAP2C mRNA | 21826169 |
| D004958 | Estradiol | Estradiol results in increased activity of TFAP2C protein | 27592001 |
| D004958 | Estradiol | Estradiol results in increased expression of TFAP2C mRNA | 26865669|2871154 |
| D004958 | Estradiol | Estradiol results in increased expression of TFAP2C mRNA | 19484750 |
| C006780 | bisphenol A | bisphenol A affects the expression of TFAP2C mRNA | 21786754 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of TFAP2C mRNA | 23557687 |
| C006780 | bisphenol A | bisphenol A affects the expression of TFAP2C mRNA | 21826169 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of TFAP2C mRNA | 29275510 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of TFAP2C mRNA | 25181051 |
| D002220 | Carbamazepine | Carbamazepine affects the expression of TFAP2C mRNA | 25979313 |
| D002330 | Carmustine | TFAP2C mRNA affects the susceptibility to Carmustine | 16365179 |
| D002857 | Chromium | Chromium results in increased expression of TFAP2C mRNA | 21437242 |
| D002994 | Clofibrate | Clofibrate results in increased expression of TFAP2C mRNA | 17585979 |
| D002996 | Clomiphene | Clomiphene results in decreased expression of TFAP2C mRNA | 26865669 |
| D003300 | Copper | Copper deficiency results in increased expression of TFAP2C mRNA | 26033743 |
| D003375 | Coumestrol | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFAP2C mRNA" | 19167446 |
| C089595 | cylindrospermopsin | cylindrospermopsin results in increased expression of TFAP2C mRNA | 24921660 |
| C014347 | decitabine | decitabine affects the expression of TFAP2C mRNA | 23300844 |
| C014347 | decitabine | [decitabine co-treated with TFAP2C protein] results in increased expression of ESR1 mRNA | 19458056 |
| C014347 | decitabine | [decitabine co-treated with TFAP2C protein] results in increased expression of RERG mRNA | 19458056 |
| C014347 | decitabine | [decitabine co-treated with trichostatin A] promotes the reaction [TFAP2C protein binds to ESR1 promoter] | 19458056 |
| C014347 | decitabine | [decitabine co-treated with trichostatin A] promotes the reaction [TFAP2C protein results in increased expression of ESR1 mRNA] | 19458056 |
| C014347 | decitabine | decitabine results in increased expression of TFAP2C mRNA | 16367923 |
| C014347 | decitabine | TFAP2C protein promotes the reaction [[decitabine co-treated with trichostatin A] results in increased expression of ESR1 mRNA] | 19458056 |
| C014347 | decitabine | TFAP2C protein promotes the reaction [[decitabine co-treated with trichostatin A] results in increased expression of RERG mRNA] | 19458056 |
| D002945 | Cisplatin | Cisplatin affects the expression of TFAP2C mRNA | 23300844 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of TFAP2C mRNA | 26865669 |
| C118739 | entinostat | entinostat results in increased expression of TFAP2C mRNA | 26272509|2718838 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| D004970 | Estrone | Estrone results in increased expression of TFAP2C mRNA | 26865669 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TFAP2C mRNA | 17942748 |
| D008656 | Mestranol | Mestranol results in increased expression of TFAP2C mRNA | 26865669 |
| C061365 | flusilazole | flusilazole affects the expression of TFAP2C mRNA | 21195148 |
| D004397 | Fonofos | Fonofos results in increased methylation of TFAP2C promoter | 22847954 |
| C070081 | fulvestrant | fulvestrant results in decreased expression of TFAP2C mRNA | 26865669 |
| D019833 | Genistein | Genistein results in increased expression of TFAP2C mRNA | 26865669 |
| D019833 | Genistein | Genistein results in increased expression of TFAP2C mRNA | 23160963 |
| C010974 | glyphosate | [Surface-Active Agents co-treated with glyphosate] results in increased expression of TFAP2C mRNA | 22467014 |
| D006427 | Hemin | Hemin results in decreased expression of TFAP2C mRNA | 20016031 |
| C409722 | hexaconazole | hexaconazole affects the expression of TFAP2C mRNA | 21195148 |
| D006589 | Hexestrol | Hexestrol results in increased expression of TFAP2C mRNA | 26865669 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of TFAP2C mRNA | 20044591 |
| C492448 | ICG 001 | ICG 001 results in decreased expression of TFAP2C mRNA | 26191083 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| D008627 | Mercuric Chloride | Mercuric Chloride affects the expression of TFAP2C mRNA | 20353558 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of TFAP2C mRNA | 23103053 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of TFAP2C mRNA | 23179753|2800136 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of TFAP2C mRNA | 26272509 |
| C004925 | methylmercuric chloride | "[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C029938 | nickel sulfate | nickel sulfate results in increased expression of TFAP2C mRNA | 22714537 |
| D017239 | Paclitaxel | Paclitaxel results in decreased expression of TFAP2C mRNA | 19682730 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of TFAP2C mRNA | 26272509 |
| D010278 | Parathion | Parathion results in increased methylation of TFAP2C promoter | 22847954 |
| C410127 | PCB 180 | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TFAP2C mRNA" | 25510870 |
| C568608 | PCI 5002 | [PCI 5002 co-treated with Zinc] results in increased expression of TFAP2C mRNA | 18593933 |
| C086401 | pentabromodiphenyl ether | pentabromodiphenyl ether results in increased expression of TFAP2C mRNA | 26705709 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of TFAP2C mRNA | 23557933 |
| C027373 | potassium chromate(VI) | potassium chromate(VI) results in increased expression of TFAP2C mRNA | 22714537 |
| D011374 | Progesterone | Progesterone results in decreased expression of TFAP2C mRNA | 22238285 |
| D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride results in decreased expression of TFAP2C mRNA | 26865669 |
| C059514 | resveratrol | resveratrol results in increased localization of and results in increased activity of TFAP2C protein | 16488535 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of TFAP2C mRNA | 25351596 |
| D013501 | Surface-Active Agents | [Surface-Active Agents co-treated with glyphosate] results in increased expression of TFAP2C mRNA | 22467014 |
| C047246 | temozolomide | TFAP2C mRNA affects the susceptibility to temozolomide | 16365179 |
| C012568 | terbufos | terbufos results in increased methylation of TFAP2C promoter | 22847954 |
| D013749 | Tetrachlorodibenzodioxin | SRC protein promotes the reaction [Tetrachlorodibenzodioxin affects the expression of TFAP2C mRNA] | 14708085 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of TFAP2C mRNA | 14708085|1696218 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TFAP2C mRNA | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of TFAP2C mRNA | 17035482|2405805 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of TFAP2C mRNA | 28065790 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased methylation of TFAP2C gene | 26756918 |
| D014118 | Toxins, Biological | "Toxins, Biological affects the expression of TFAP2C mRNA" | 19682533 |
| C032910 | triadimefon | triadimefon affects the expression of TFAP2C mRNA | 21195148 |
| C012589 | trichostatin A | [decitabine co-treated with trichostatin A] promotes the reaction [TFAP2C protein binds to ESR1 promoter] | 19458056 |
| C012589 | trichostatin A | [decitabine co-treated with trichostatin A] promotes the reaction [TFAP2C protein results in increased expression of ESR1 mRNA] | 19458056 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C012589 | trichostatin A | TFAP2C protein promotes the reaction [[decitabine co-treated with trichostatin A] results in increased expression of ESR1 mRNA] | 19458056 |
| C012589 | trichostatin A | TFAP2C protein promotes the reaction [[decitabine co-treated with trichostatin A] results in increased expression of RERG mRNA] | 19458056 |
| C012589 | trichostatin A | [trichostatin A co-treated with TFAP2C protein] results in increased expression of ESR1 mRNA | 19458056 |
| C012589 | trichostatin A | [trichostatin A co-treated with TFAP2C protein] results in increased expression of RERG mRNA | 19458056 |
| C012589 | trichostatin A | trichostatin A results in increased expression of TFAP2C mRNA | 24935251|2627250 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of TFAP2C mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of TFAP2C mRNA | 23179753|2438349 |
| D014638 | Vanadates | Vanadates results in decreased expression of TFAP2C mRNA | 22714537 |
| C025643 | vinclozolin | vinclozolin results in decreased expression of TFAP2C mRNA | 23034163 |
| D024483 | Vitamin K 3 | Vitamin K 3 results in increased expression of TFAP2C mRNA | 25270620 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in increased expression of TFAP2C mRNA | 26272509 |
| D015032 | Zinc | [PCI 5002 co-treated with Zinc] results in increased expression of TFAP2C mRNA | 18593933 |